# Boston Medical Center Corporation

Canonical: https://abierto.us/vendors/boston-medical-center-corporation-jz8rqc4emdz5

- UEI: JZ8RQC4EMDZ5
- CAGE: 09PZ2
- Location: Boston, MA
- Awards in window: 13 (24 transactions), $1,547,784 obligated, March 13, 2025 to September 13, 2026

## Awarding agencies

- National Institutes of Health: 7 awards, $582,970
- Department of Veterans Affairs: 4 awards, $527,191
- Centers for Disease Control and Prevention: 2 awards, $437,623

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $595,255
- 611310 Colleges, Universities, and Professional Schools: $527,191
- 622110 General Medical and Surgical Hospitals: $437,623
- 622310 Specialty (except Psychiatric and Substance Abuse) Hospitals: $0
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): -$12,285

## Competition

- Full and Open Competition: 9 awards
- Not Available for Competition: 3 awards
- Not Competed: 1 awards

## Largest awards

- 75N94025F00001 (delivery order): $599,807, National Institutes of Health Nichd. Nichd: R&d: a Phase 2B Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception: Non-Severable. https://www.usaspending.gov/award/CONT_AWD_75N94025F00001_7529_75N94020D00004_7529/
- 75D30123F00001 (delivery order): $437,623, CDC Office of Acquisition Services. 2023 Clinical Immunization Safety Assessment (Cisa) Base IDIQ. https://www.usaspending.gov/award/CONT_AWD_75D30123F00001_7523_75D30123D17920_7523/
- 36C24125C0070 (definitive contract): $350,496, 241-Network Contract Office 01. Education Cost Sharing. https://www.usaspending.gov/award/CONT_AWD_36C24125C0070_3600_-NONE-_-NONE-/
- 36C24126C0007 (definitive contract): $127,142, 241-Network Contract Office 01. Ophthalmology Physician Services. https://www.usaspending.gov/award/CONT_AWD_36C24126C0007_3600_-NONE-_-NONE-/
- 36C24124C0086 (definitive contract): $49,554, 241-Network Contract Office 01. Onsite Ophthalmology Services. https://www.usaspending.gov/award/CONT_AWD_36C24124C0086_3600_-NONE-_-NONE-/
- 75N94020F00001 (delivery order): $8,186, National Institutes of Health Nichd. Eoi:: Implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Nichd: Service: Core Function Activities: Severable: Bilateral Modification to Descope. https://www.usaspending.gov/award/CONT_AWD_75N94020F00001_7529_75N94020D00004_7529/
- 36C24121C0047 (definitive contract): $0, 241-Network Contract Office 01. Education Costs. https://www.usaspending.gov/award/CONT_AWD_36C24121C0047_3600_-NONE-_-NONE-/
- 75N94018F00003 (delivery order): $0, National Institutes of Health Nichd. Nichd: R&d: to Evaluate in Obese and NON-OBESE Women the Pharmacokinetics and the Pharmacodynamic Effects, Cycle Control, and Safety of Levonorgestrel Butanoate (Lb) Formulated as a Long-Acting Injectable: Non-Severable. https://www.usaspending.gov/award/CONT_AWD_75N94018F00003_7529_HHSN275201300017I_7529/
- 75D30123D17920: $0, CDC Office of Acquisition Services. Eo 14398. https://www.usaspending.gov/award/CONT_IDV_75D30123D17920_7523/
- 75N94020D00004: $0, National Institutes of Health Nichd. Nichd: R&d: to Conduct Phase I, Ii, III or IV Contraceptive Trials in Women, Treatment Trials of Gynecologic Conditions Such as Endometriosis or Leiomyomata, and Development of Research Protocols on a Task Order Basis: Non-Severable. https://www.usaspending.gov/award/CONT_IDV_75N94020D00004_7529/
- 75N94021D00003: $0, National Institutes of Health Nichd. EO14398 Clinical Research Sites for the Niaaa Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder. https://www.usaspending.gov/award/CONT_IDV_75N94021D00003_7529/
- 75N94021F00001 (delivery order): -$12,285, National Institutes of Health Nichd. Core Function Activities Task Order for Advisory Services and Administrative Reporting. https://www.usaspending.gov/award/CONT_AWD_75N94021F00001_7529_75N94021D00003_7529/
- 75N94023F00001 (delivery order): -$12,738, National Institutes of Health Nichd. Nichd: R&d: Ovaprene Vaginal Device Clinical Trial: Non-Severable FY22 Can 8054183. https://www.usaspending.gov/award/CONT_AWD_75N94023F00001_7529_75N94020D00004_7529/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/boston-medical-center-corporation-jz8rqc4emdz5.